These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11096129)

  • 1. Degranulation of polymorphonuclear leukocytes by dialysis membranes--the mystery clears up?
    Schmaldienst S; Hörl WH
    Nephrol Dial Transplant; 2000 Dec; 15(12):1909-10. PubMed ID: 11096129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis.
    Bos JC; Grooteman MP; van Houte AJ; Schoorl M; van Limbeek J; Nubé MJ
    Nephrol Dial Transplant; 1997 Jul; 12(7):1387-93. PubMed ID: 9249774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis-induced degranulation of polymorphonuclear cells: no correlation between membrane markers and degranulation products.
    Grooteman MP; van Tellingen A; van Houte AJ; Bos JC; Schoorl M; van Limbeek J; Nubé MJ
    Nephron; 2000 Jul; 85(3):267-74. PubMed ID: 10867543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic response of neutrophils to uremia and dialysis.
    Haag-Weber M; Hable M; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S293-8. PubMed ID: 2699999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of demineralized bone matrix on polymorphonuclear leukocyte degranulation.
    Kale AA; Clancy R; Leslie MP; Di Cesare PE
    J Orthop Res; 1999 Jul; 17(4):598-606. PubMed ID: 10459769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of degranulation of human polymorphonuclear leukocytes by complement factor D.
    Balke N; Holtkamp U; Hörl WH; Tschesche H
    FEBS Lett; 1995 Sep; 371(3):300-2. PubMed ID: 7556615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis.
    Schaefer RM; Herfs N; Ormanns W; Hörl WH; Heidland A
    Clin Nephrol; 1988 Jun; 29(6):307-11. PubMed ID: 3396234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.
    Schmaldienst S; Oberpichler A; Tschesche H; Hörl WH
    Kidney Blood Press Res; 2003; 26(2):107-12. PubMed ID: 12771535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system.
    Koller H; Hochegger K; Zlabinger GJ; Lhotta K; Mayer G; Rosenkranz AR
    Nephrol Dial Transplant; 2004 Dec; 19(12):3104-11. PubMed ID: 15575000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
    Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
    Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hemosorbents on the structure of polymorphonuclear leukocytes in man].
    Iakubovskaia RI; Ivanova LM; Nemtsova ER; Vorotyntsev AP; Vavilov MP
    Anesteziol Reanimatol; 1992; (3):55-8. PubMed ID: 1463239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear granulocyte stimulation by cellulose-based hemodialysis membranes.
    Körmöczi GF; Rosenkranz AR; Zlabinger GJ
    Clin Chem Lab Med; 1999 Mar; 37(3):351-5. PubMed ID: 10353482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.
    Hörl WH
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S62-71. PubMed ID: 11792764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stimulated chemiluminescence and degranulation of human polymorphonuclear leukocytes: possible involvement in the mechanisms of tissue damage during inflammation].
    Cui X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):90-5. PubMed ID: 1652381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
    Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
    Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes.
    Schauer S; Stein G; Süss J; Falkenhagen D; Linss W
    Nephrol Dial Transplant; 1991; 6 Suppl 3():35-40. PubMed ID: 1775265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.